Form 4 for IGC IGC Pharma, Inc.
Accepted 2024-03-15 00:00:00 ET · period of report 2024-03-13 · accession 0001185185-24-000264 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-15 | 2024-03-13 | IGC | GRIMALDI CLAUDIA | Dir | M - OptEx | $0.00 | +336.7K | 842.2K | +67% | $0 |
| DM | 2024-03-15 | 2024-03-13 | IGC | GRIMALDI CLAUDIA | Dir | A - Grant | $0.00 | +910.0K | 360.0K | New | $0 |
| DM | 2024-03-15 | 2024-03-13 | IGC | GRIMALDI CLAUDIA | Dir | M - OptEx | $0.00 | -336.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-13 | M | A | 83,333 | $0.00 | 783,821 | D | — | — | (F1) On July 19, 2021, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2022. |
| 2 | Common | Common Stock | 2024-03-13 | M | A | 95,000 | $0.00 | 1,037,154 | D | — | — | (F4) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved. |
| 3 | Common | Common Stock | 2024-03-13 | M | A | 100,000 | $0.00 | 942,154 | D | — | — | (F3) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2024. |
| 4 | Common | Common Stock | 2024-03-13 | M | A | 58,333 | $0.00 | 842,154 | D | — | — | (F2) On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2023. |
| 5 | Derivative | Options | 2024-03-13 | A | A | 550,000 | $0.00 | 550,000 | D | — · — to 2034-03-31 | 550,000 Common Stock | (F7) On March 13, 2024, the Reporting Person was granted Options subject to vesting according to specific milestones set by the Company's Board of Directors. The Options vest when milestones are achieved. The exercise price is $0.26. |
| 6 | Derivative | Options | 2024-03-13 | A | A | 360,000 | $0.00 | 360,000 | D | — · — to — | 360,000 Common Stock | (F6) On March 13, 2024, the Reporting Person was granted Options subject to vesting equally over three years starting on March 2025. The exercise price is $0.26. |
| 7 | Derivative | Restricted Stock Units | 2024-03-13 | M | D | 95,000 | $0.00 | 285,000 | D | — · — to 2033-03-31 | 95,000 Common Stock | (F4) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved. (F5) Each restricted stock unit represents a right to receive one share of IGC common stock. |
| 8 | Derivative | Restricted Stock Units | 2024-03-13 | M | D | 100,000 | $0.00 | 200,000 | D | — · — to — | 100,000 Common Stock | (F3) On June 20, 2023, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2024. (F5) Each restricted stock unit represents a right to receive one share of IGC common stock. |
| 9 | Derivative | Restricted Stock Units | 2024-03-13 | M | D | 58,334 | $0.00 | 58,332 | D | — · — to — | 58,334 Common Stock | (F2) On May 25, 2022, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2023. (F5) Each restricted stock unit represents a right to receive one share of IGC common stock. |
| 10 | Derivative | Restricted Stock Units | 2024-03-13 | M | D | 83,333 | $0.00 | 0 | D | — · — to — | 83,333 Common Stock | (F1) On July 19, 2021, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 2022. (F5) Each restricted stock unit represents a right to receive one share of IGC common stock. |